Cardiovascular Risk in Essential Thrombocythemia and Polycythemia Vera: Thrombotic Risk and Survival

Thromboembolic and bleeding events pose a severe risk for patients with Polycythemia Vera (PV) and Essential Thrombocythemia (ET). Many factors can contribute to promoting the thrombotic event due to the interaction between platelets, leukocytes, and endothelium alterations. Moreover, a significant...

Full description

Saved in:
Bibliographic Details
Published in:Mediterranean journal of hematology and infectious diseases 2020, Vol.12 (1), p.e2020008-e2020008
Main Authors: Accurso, Vincenzo, Santoro, Marco, Mancuso, Salvatrice, Contrino, Angelo Davide, Casimiro, Paolo, Sardo, Mariano, Raso, Simona, Di Piazza, Florinda, Perez, Alessandro, Bono, Marco, Russo, Antonio, Siragusa, Sergio
Format: Article
Language:English
Subjects:
Essential Thrombocythemia
Original
Polycythemia Vera
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Thromboembolic and bleeding events pose a severe risk for patients with Polycythemia Vera (PV) and Essential Thrombocythemia (ET). Many factors can contribute to promoting the thrombotic event due to the interaction between platelets, leukocytes, and endothelium alterations. Moreover, a significant role can be played by cardiovascular risk factors (CV.R) such as cigarette smoking habits, hypertension, diabetes, obesity and dyslipidemia. In this study, we evaluated the impact that CV.R plays on thrombotic risk and survival in patients with PV and ET.
ISSN:2035-3006
2035-3006
DOI:10.4084/MJHID.2020.008